Mark A. Exley

Also affiliated with PaxVax (United States)

Immunology and MicrobiologyMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “Targeted immunotherapy for glioblastoma involving whole tumor-derived autologous cells in the upfront setting after craniotomy”.

Targeted immunotherapy for glioblastoma involving whole tumor-derived autologous cells in the upfront setting after craniotomy

Journal of Neuro-Oncology(2023)10.1007/s11060-023-04491-4

N/A

0.319DataRank · unranked

4 citations

Jenny Zilberberg, Raul Perez-Olle, Mark A. Exley, David W. Andrews, Carrie E. Andrews

Invariant NKT cell-augmented GM-CSF-secreting tumor vaccine is effective in advanced prostate cancer model

Cancer Immunology Immunotherapy(2022)10.1007/s00262-022-03210-8

N/A

0DataRank · unranked

5 citations

Lydia Lynch, Lianne Vriend, Dobrin Draganov, Justice Clark, Haydn Kissick +7 more

Innate iNKT cells: from biological insight to clinical impact

Frontiers in Immunology(2025)10.3389/fimmu.2025.1653183

N/A

0DataRank · unranked

6 citations

Nicola J. Mason, Mark A. Exley, Antonia Rotolo